|
1
|
Huse JT and Holland EC: Targeting brain
cancer: Advances in the molecular pathology of malignant glioma and
medulloblastoma. Nat Rev Cancer. 10:319–331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thomas AA, Brennan CW, DeAngelis LM and
Omuro AM: Emerging therapies for glioblastoma. JAMA Neurol.
71:1437–1444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee KH, Ahn EJ, Oh SJ, Kim O, Joo YE, Bae
JA, Yoon S, Ryu HH, Jung S, Kim KK, et al: KITENIN promotes glioma
invasiveness and progression, associated with the induction of EMT
and stemness markers. Oncotarget. 6:3240–3253. 2015.PubMed/NCBI
|
|
4
|
Diksin M, Smith SJ and Rahman R: The
molecular and phenotypic basis of the glioma invasive perivascular
niche. Int J Mol Sci. 18:pii: E23422017. View Article : Google Scholar
|
|
5
|
Guo L, Sang M, Liu Q, Fan X, Zhang X and
Shan B: The expression and clinical significance of
melanoma-associated antigen-A1, -A3 and -A11 in glioma. Oncol Lett.
6:55–62. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van der Bruggen P, Traversari C, Chomez P,
Lurquin C, De Plaen E, Van den Eynde B, Knuth A and Boon T: A gene
encoding an antigen recognized by cytolytic T lymphocytes on a
human melanoma. Science. 254:1643–1647. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee AK and Potts PR: A comprehensive guide
to the MAGE family of ubiquitin ligases. J Mol Biol. 429:1114–1142.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chomez P, De Backer O, Bertrand M, De
Plaen E, Boon T and Lucas S: An overview of the MAGE gene family
with the identification of all human members of the family. Cancer
Res. 61:5544–5551. 2001.PubMed/NCBI
|
|
9
|
Krämer BF, Schoor O, Krüger T, Reichle C,
Müller M, Weinschenk T, Hennenlotter J, Stenzl A, Rammensee HG and
Stevanovic S: MAGED4-expression in renal cell carcinoma and
identification of an HLA-A'25-restricted MHC class I ligand from
solid tumor tissue. Cancer Biol Ther. 4:943–948. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma QY, Pang LW, Chen ZM, Zhu YJ, Chen G
and Chen J: The significance of MAGED4 expression in non-small cell
lung cancer as analyzed by real-time fluorescence quantitative PCR.
Oncol Lett. 4:733–738. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Germano S, Kennedy S, Rani S, Gleeson G,
Clynes M, Doolan P, McDonnell S, Hughes L, Crown J and O'Driscoll
L: MAGE-D4B is a novel marker of poor prognosis and potential
therapeutic target involved in breast cancer tumorigenesis. Int J
Cancer. 130:1991–2002. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chong CE, Lim KP, Gan CP, Marsh CA, Zain
RB, Abraham MT, Prime SS, Teo SH, Silvio Gutkind J, Patel V and
Cheong SC: Over-expression of MAGED4B increases cell migration and
growth in oral squamous cell carcinoma and is associated with poor
disease outcome. Cancer Lett. 321:18–26. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takami H, Kanda M, Oya H, Hibino S,
Sugimoto H, Suenaga M, Yamada S, Nishikawa Y, Asai M, Fujii T, et
al: Evaluation of MAGE-D4 expression in hepatocellular carcinoma in
Japanese patients. J Surg Oncol. 108:557–562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oya H, Kanda M, Takami H, Hibino S,
Shimizu D, Niwa Y, Koike M, Nomoto S, Yamada S, Nishikawa Y, et al:
Overexpression of melanoma-associated antigen D4 is an independent
prognostic factor in squamous cell carcinoma of the esophagus. Dis
Esophagus. 28:188–195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang QM, He SJ, Shen N, Luo B, Fan R, Fu
J, Luo GR, Zhou SF, Xiao SW and Xie XX: Overexpression of MAGE-D4
in colorectal cancer is a potentially prognostic biomarker and
immunotherapy target. Int J Clin Exp Pathol. 7:3918–3927.
2014.PubMed/NCBI
|
|
16
|
He SJ, Gu YY, Yu L, Luo B, Fan R, Lin WZ,
Lan XW, Lin YD, Zhang QM, Xiao SW and Xie XX: High expression and
frequently humoral immune response of melanoma-associated antigen
D4 in glioma. Int J Clin Exp Pathol. 7:2350–2360. 2014.PubMed/NCBI
|
|
17
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang QM, Shen N, Xie S, Bi SQ, Luo B, Lin
YD, Fu J, Zhou SF, Luo GR, Xie XX and Xiao SW: MAGED4 expression in
glioma and upregulation in glioma cell lines with
5-aza-2′-deoxycytidine treatment. Asian Pac J Cancer Prev.
15:3495–3501. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sasaki M, Nakahira K, Kawano Y, Katakura
H, Yoshimine T, Shimizu K, Kim SU and Ikenaka K: MAGE-E1, a new
member of the melanoma-associated antigen gene family and its
expression in human glioma. Cancer Res. 61:4809–4814.
2001.PubMed/NCBI
|
|
20
|
Parney IF, Hao C and Petruk KC: Glioma
immunology and immunotherapy. Neurosurgery. 46:778–792. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kimura M: A simple method for estimating
evolutionary rates of base substitutions through comparative
studies of nucleotide sequences. J Mol Evol. 16:111–120. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ito S, Kawano Y, Katakura H, Takenaka K,
Adachi M, Sasaki M, Shimizu K, Ikenaka K, Wada H and Tanaka F:
Expression of MAGE-D4, a novel MAGE family antigen, is correlated
with tumor-cell proliferation of non-small cell lung cancer. Lung
Cancer. 51:79–88. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thaker PH, Deavers M, Celestino J,
Thornton A, Fletcher MS, Landen CN, Kinch MS, Kiener PA and Sood
AK: EphA2 expression is associated with aggressive features in
ovarian carcinoma. Clin Cancer Res. 10:5145–5150. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han ZG, Jiang WG, Hiscox S, Hallett MB,
Isoai A and Mansel RE: Inhibition of motility and invasion of human
lung cancer cells by invasion inhibiting factor 2. Surg Oncol.
5:77–84. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao W, Zhou Y, Xu H, Cheng Y and Kong B:
Snail family proteins in cervical squamous carcinoma: Expression
and significance. Clin Invest Med. 36:E223–E233. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song X, Zhang W, Zhang Y, Zhang H, Fu Z,
Ye J, Liu L, Song X and Wu Y: Expression of semaphorin 3A and
neuropilin 1 with clinicopathological features and survival in
human tongue cancer. Med Oral Patol Oral Cir Bucal. 17:e962–e968.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu LK, Jiang XY, Zhou XX, Wang DM, Song
XL and Jiang HB: Upregulation of vimentin and aberrant expression
of E-cadherin/beta-catenin complex in oral squamous cell
carcinomas: Correlation with the clinicopathological features and
patient outcome. Mod Pathol. 23:213–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Szopa W, Burley TA, Kramer-Marek G and
Kaspera W: Diagnostic and therapeutic biomarkers in glioblastoma:
Current status and future perspectives. Biomed Res Int.
2017:80135752017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheong SC, Chandramouli GV, Saleh A, Zain
RB, Lau SH, Sivakumaren S, Pathmanathan R, Prime SS, Teo SH, Patel
V and Gutkind JS: Gene expression in human oral squamous cell
carcinoma is influenced by risk factor exposure. Oral Oncol.
45:712–719. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsai JR, Chong IW, Chen YH, Yang MJ, Sheu
CC, Chang HC, Hwang JJ, Hung JY and Lin SR: Differential expression
profile of MAGE family in non-small-cell lung cancer. Lung Cancer.
56:185–192. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mathieu MG, Linley AJ, Reeder SP, Badoual
C, Tartour E, Rees RC and McArdle SE: HAGE, a cancer/testis antigen
expressed at the protein level in a variety of cancers. Cancer
Immun. 10:22010.PubMed/NCBI
|
|
33
|
Chen G, Gharib TG, Huang CC, Taylor JM,
Misek DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB,
Hanash SM and Beer DG: Discordant protein and mRNA expression in
lung adenocarcinomas. Mol Cell Proteomics. 1:304–313. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Karim AB, Maat B, Hatlevoll R, Menten J,
Rutten EH, Thomas DG, Mascarenhas F, Horiot JC, Parvinen LM, van
Reijn M, et al: A randomized trial on dose-response in radiation
therapy of low-grade cerebral glioma: European Organization for
Research and Treatment of Cancer (EORTC) study 22844. Int J Radiat
Oncol Biol Phys. 36:549–556. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Daniels TB, Brown PD, Felten SJ, Wu W,
Buckner JC, Arusell RM, Curran WJ, Abrams RA, Schiff D and Shaw EG:
Validation of EORTC prognostic factors for adults with low-grade
glioma: A report using intergroup 86-72-51. Int J Radiat Oncol Biol
Phys. 81:218–224. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bouvier-Labit C, Chinot O, Ochi C,
Gambarelli D, Dufour H and Figarella-Branger D: Prognostic
significance of Ki67, p53 and epidermal growth factor receptor
immunostaining in human glioblastomas. Neuropathol Appl Neurobiol.
24:381–388. 1998. View Article : Google Scholar : PubMed/NCBI
|
